Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Judith White

18PUBLICATIONS
35CO-AUTHORS
Nanotoxicology, health and safetyClinical pharmacology and therapeuticsBiofabricationInnate immunityPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

Sort by Publication Date:
|Jun 28, 2024
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.

Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner

|Mar 12, 2024
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents.

Shuang Xu, Shadisadat Esmaeili, E Fabian Cardozo-Ojeda

|Sep 20, 2023
A novel <i>in vitro</i> system of supported planar endosomal membranes (SPEMs) reveals an enhancing role for cathepsin B in the final stage of Ebola virus fusion and entry.

Laura Odongo, Betelihem H Habtegebrael, Volker Kiessling

|Mar 22, 2023
Serinc5 Restricts HIV Membrane Fusion by Altering Lipid Order and Heterogeneity in the Viral Membrane.

Amanda E Ward, Daria Sokovikova, Melvin Neal Waxham

|Oct 03, 2022
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.

Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang

|Dec 22, 2021
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.

Judith M White, Joshua T Schiffer, Rachel A Bender Ignacio

Pageof 3

Frequent Collaborators

5 joint publications

Stephen J Polyak

2 joint publications

Joshua T Schiffer

2 joint publications

Mary F Paine

2 joint publications

Lukas K Tamm

2 joint publications

Tero Aittokallio

1 joint publications

Volker Kiessling

1 joint publications

Barbie K Ganser-Pornillos

1 joint publications

Steve M Varga

1 joint publications

Noah S Butler

1 joint publications

Gail A Bishop

Frequent Collaborators

5 joint publications

Stephen J Polyak

2 joint publications

Joshua T Schiffer

2 joint publications

Mary F Paine

2 joint publications

Lukas K Tamm

Top Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on : Jun 05, 2021

4.6K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

18.6K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

36.3K
See more related videos

Top Related Videos

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on : Jun 05, 2021

4.6K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

18.6K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on : Sep 27, 2014

36.3K
See more related videos